Testing effectiveness (Phase 2)Study completedNCT01930162
What this trial is testing
Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant
Who this might be right for
Single Umbilical Cord Blood TransplantationNon-myeloablative ConditioningAcute Lymphocytic Leukemia+4 more
Novartis Pharmaceuticals 9